KalVista Pharmaceuticals, Inc. Share Price & Technical Analysis
KALV · $26.79 (+0.07%)
Healthcare / Biotechnology
$26.79
+0.07%
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kallikrein for the treatment of acute attacks of hereditary angioedema (HAE). The company is also developing is developing an orally disintegrating tablet formulation; KONFIDENT-KID f…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
0% return in May, 1% avg return in past 3 year May month.
56% return in 2026, 44% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -4% | 4% | 26% | 29% | 0% | – | – | – | – | – | – | – | 56% |
| 25 | 3% | 30% | 0% | 20% | -15% | -6% | 21% | -1% | -10% | -11% | 34% | 13% | 80% |
| 24 | 26% | -14% | -13% | -3% | 3% | 2% | 24% | -8% | -13% | -10% | -2% | -15% | -24% |
| 23 | 21% | -8% | 7% | 8% | 15% | -7% | 12% | 6% | -12% | -11% | 2% | 44% | 77% |
| 22 | -5% | 27% | -8% | -14% | -30% | 9% | 27% | 35% | -12% | -65% | 6% | 26% | -4% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Strong
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kallikrein for the treatment of acute attacks of hereditary angioedema (HAE). The company is also developing is developing an orally disintegrating tablet formulation; KONFIDENT-KID for pediatric use with HAE; KONFIDENT; and KONFIDENT-S to evaluate sebetralstat and ODT formulation in adolescent and adult patients. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.42B
P/E ratio
—
52W high
$26.85
52W low
$9.83
Volume
15,65,725
Beta
-0.12
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is KalVista Pharmaceuticals, Inc. share price today?
- KalVista Pharmaceuticals, Inc. (KALV) last traded around $26.79 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does KALV have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for KALV. Download the app for real-time alerts.
- How can I analyze KalVista Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.